Skip to content
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France

Search

  • Home
  • About Us
    • Cardiawave
    • Mission and values
    • The Team
    • Careers
  • Aortic Stenosis
    • Unmet Medical Need
    • Current Treatment
  • Health Professionals
    • Our device: Valvosoft® 
    • Scientific Publications
    • Congresses
  • News
    • News
    • Press releases
  • Contact
About Us

📢 Cardiawave welcomes Hardip Thakerar to its Board of Directors!

Feb 16, 2026 HeleneCardiawave 0
About Us

🎉 Cardiawave has just reached 8,000 followers on LinkedIn!

Jan 29, 2026 HeleneCardiawave 0
About Us

Congratulations to Prof. Hélène Eltchaninoff on becoming President of the French Society of Cardiology! 🎉

Jan 22, 2026 HeleneCardiawave 0
About Us

🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025

Jan 13, 2026 HeleneCardiawave 0
Events

Cardiawave at JESFC 2026!

Jan 8, 2026 HeleneCardiawave 0
Press Release

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

Dec 4, 2025 HeleneCardiawave 0

Blog

About Us

📢 Cardiawave welcomes Hardip Thakerar to its Board of Directors!

Feb 16, 2026
READ MORE
About Us

🎉 Cardiawave has just reached 8,000 followers on LinkedIn!

Jan 29, 2026
READ MORE
About Us

Congratulations to Prof. Hélène Eltchaninoff on becoming President of the French Society of Cardiology! 🎉

Jan 22, 2026
READ MORE
About Us

🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025

Jan 13, 2026
READ MORE
Events

Cardiawave at JESFC 2026!

Jan 8, 2026
READ MORE
Press Release

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

Dec 4, 2025
READ MORE
Press Release

VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE

Dec 4, 2025
READ MORE
Events

📢 Cardiawave’s Valvosoft® to be presented at PCR London Valves 2025!

Nov 6, 2025
READ MORE
Press Release

Cardiawave renforce son leadership avec la nomination de Jonathan Freeman, Président du CA

Oct 30, 2025
READ MORE
Press Release

Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman

Oct 23, 2025
READ MORE

Posts pagination

Page 1 Page 2 … Page 22 NextNext page

Categories

  • About Us
  • Aortic Stenosis
  • Careers
  • Clinical Studies
  • Corporate News
  • Events
  • Other news
  • Press Release
  • Scientific Publications

Featured Posts

About Us

📢 Cardiawave welcomes Hardip Thakerar to its Board of Directors!

Feb 16, 2026 HeleneCardiawave 0
About Us

🎉 Cardiawave has just reached 8,000 followers on LinkedIn!

Jan 29, 2026 HeleneCardiawave 0
About Us

Congratulations to Prof. Hélène Eltchaninoff on becoming President of the French Society of Cardiology! 🎉

Jan 22, 2026 HeleneCardiawave 0
About Us

🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025

Jan 13, 2026 HeleneCardiawave 0
Events

Cardiawave at JESFC 2026!

Jan 8, 2026 HeleneCardiawave 0
Press Release

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

Dec 4, 2025 HeleneCardiawave 0

l Latest news

  • 📢 Cardiawave welcomes Hardip Thakerar to its Board of Directors!
  • 🎉 Cardiawave has just reached 8,000 followers on LinkedIn!

l Our social networks

  • LinkedIn
  • Twitter

l Contact Us

3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
+ 33 (0) 1 55 26 82 16
contact@cardiawave.com

Copyright © Cardiawave l February 5th 2026
  • Legal Mentions